Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
Fifty-plus years of unbroken dividend raises sounds like a floor, but not every Dividend King deserves a permanent seat in your portfolio right now. Five do, and one of them is actually trading at a discount that long-term income investors rarely get handed.
Rolling $880,000 into a self-directed IRA sounds like a clean break from the 9-to-5, but generating $5,200 a month from that balance forces a choice between safety and survival that most retirement calculators never show you.
Pulling $54,000 a year from a $950,000 rollover IRA sounds like a math problem, but the real trap is hidden in the yield tier you choose and what it quietly does to your principal over time.
Four Dividend Aristocrats were flagged as stealth growth plays a year ago, and the results cut sharply in two directions. See which names delivered and which stumbled, plus three fresh picks where the dividend coverage story is quietly getting stronger.
While the rest of the market chased AI headlines and flinched at every tariff rumor, three famously unglamorous stocks kept raising their dividends and quietly compounding wealth. Here is why August may be the right moment to pay attention.
These blue-chip consumer companies -- Procter & Gamble, McDonald's, and Coca-Cola -- offer reliable, growing dividends backed by resilient businesses and strong cash flow.
This consumer staples Dividend King is down nearly 20% since its 2024 high despite its industry-leading business.
With the 10-year Treasury yield near 4.70%, dividend stocks face a real test of relevance, and only a handful of names have the streak length and earnings power to still make the cut right now.
Procter & Gamble (NYSE:PG) agreed to acquire Thorne, a science-focused wellness supplements company. The transaction values Thorne at US$3.8b and expands PG into premium health and wellness categories. The deal centers on vitamins, minerals, and supplements as an extension of PG's existing health portfolio. For investors tracking Procter & Gamble, this move pushes the company further into consumer health and wellness rather than relying only on traditional household and personal care...
The consumer-goods giant will buy Thorne to bolster its presence in the beauty and wellness industry.
Your portfolio could be paying you quarterly income right now from three companies that have raised their dividends for decades straight, but the next ex-dates are approaching fast and missing them means waiting another quarter to collect.
A 3% yield near a 52-week low is tempting -- but the new guidance explains why I'm waiting.
Stock Market Today: The Dow Jones index dropped Wednesday ahead of the Fed decision and Fed Chair Warsh's comments. SK Hynix sold off.
Shares of Procter & Gamble declined in premarket trading Wednesday as Wall Street reacted to mixed quarterly earnings and underwhelming profit guidance from the consumer packaged goods company. Procter & Gamble posted core earnings of $1.43 a share for the fiscal fourth quarter, down from $1.48 a year ago but slightly above Wall Street expectations of $1.41. It was a mixed bag for Procter & Gamble’s product categories—which range from baby care to hair care.
Coca-Cola and Boeing are surging together for the first time in years as investors abandon AI darlings, and the catalyst behind each stock tells a very different story about where the market is heading.
Procter & Gamble usually isn't an exciting stock -- and that may be the reason to consider it, heading into earnings.
Procter & Gamble is about to report earnings, and its earnings update may not be great reading.
Colgate-Palmolive (CL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HDV quietly stacks a 3.1% income stream on top of equity gains that have left the S&P 500 in the dust this year, but the fund's concentrated sector bets carry a catch that most yield-seekers overlook.
NWL vs. PG: Which Stock Is the Better Value Option?
Three dividend growers with very different setups are quietly positioning long-term investors for decades of rising income, but each one carries a specific risk in the second half of 2026 that could shake out impatient holders before the real compounding begins.
With 10-year Treasuries near 4.62%, VYM's $94.6 billion portfolio faces a real test from risk-free yields, and two familiar names inside the fund are quietly raising red flags about future income growth.
The latest trading day saw Procter & Gamble (PG) settling at $148.05, representing a +1.35% change from its previous close.
Megacap stocks dominate their sectors and their actions influence economies worldwide. The flip side though is that their sheer size means they have less room for explosive growth as scale works against them.
A share of Johnson & Johnson (NYSE: JNJ) paid $0.25 per quarter in dividends in 1999. That same share pays $1.34 per quarter in 2026. The stock price has moved through plenty of cycles since then, but the income stream alone has more than quintupled without the investor doing anything except holding. That trajectory is ... The Case For Buying Smaller Dividends That Grow Faster
Five Dividend Kings—Procter & Gamble, Hormel, Stanley Black & Decker, Genuine Parts and Lowe's—trade at discounted valuations, offering attractive yields despite near-term business headwinds.
Procter & Gamble and Progressive are among the stocks that could rise after reporting earnings, according to Citi strategist Scott Chronert.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
